public-health-hospital-management-2018-tracks.digital

Notes:

conferenceseries LLC Ltd

Page 42

December 03-04, 2018 | Lisbon, Portugal

Public Health, Women's Health, Nursing and Hospital Management

Joint Event

Journal of Community Medicine & Health Education | ISSN : 2161-0711 | Volume 08

Hospital-acquired infections by carbapenem-resistant Gram-negative

bacteria: An old hospital management challenge in a new technology era

he acquisition and emergence of carbapenem resistance among Gram-negative bacteria (GNB)

is a major cause of concern, since carbapenems currently represent the treatment of choice

for severe infections caused by multidrug-resistant (MDR) strains producing extended-spectrum

β-lactamases (ESBL). In 2017, the World Health Organization had published a global priority

pathogens list of antibiotic-resistant bacteria to help in prioritizing the research and development

of new and effective antibiotic treatments. In this list, it identified carbapenem-resistant

Enterobacteriaceae

(which includes

Klebsiella pneumoniae

and

Escherichia

coli),

Pseudomonas

aeruginosa and Acinetobacter baumannii,

as the top three critical threats. Although great efforts

have been made to enhance epidemiological surveillance in Europe, virulence traits and molecular

characterization of carbapenem-resistant isolates from some countries remains scarce. Additionally,

it remains somewhat unclear how pathogenic bacteria, its resistance and virulence, have evolved

in over the time and its relationship with the healthcare system changes imposed by medical

technologies. All combined, this thematic can constitute an important threat to safety patients, a

significative economic burden and a serious challenge to hospital management.

Biography

Catia Sofia Gabriel Caneiras has completed her graduation in Pharmaceutical Sciences (Pharm D) from University

of Lisbon (Faculty of Pharmacy) and Master’s degree in Clinical Microbiology (MSc) in the Faculty of Medicine from

the same university. Currently, she is a PhD student in the field of Health Sciences and Technologies, specialty

in Microbiology. She is working as the Healthcare Business Director and Scientific Director of Praxair Portugal

and she is responsible for the telemedicine development area. She is a Senior Researcher in the Department of

Microbiology and Immunology at FFUL and Invited Researcher at the Institute of Environmental Health. She has

participated in more than 100 scientific activities, including 25 oral communications and 30 publications. She is an

invited Reviewer of Journal of Medical Microbiology, Microorganisms, Journal of Clinical Medicine and International

Journal of Environment and Public Health

Catia Sofia Gabriel Caneiras

University of Lisbon, Portugal

Catia Sofia Gabriel Caneiras, J Community Med Health Educ 2018, Volume:8

DOI: 10.4172/2161-0711-C7-050